Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antoine Morel

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Clinical Kidney Journal|August 2, 2023
CD44 staining in parietal epithelial cells and early steroid response in patients with minimal change diseaseAntoine Morel, Philippe Remy, Hamza Sakhi, et al.
Pathology|November 14, 2021
Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosisAntoine Morel, David Buob, Jean-Michel Goujon, et al.
Phlebology|January 7, 2021
Management of superficial venous thrombosis in unevaluated situations: Cancer, severe renal impairment, pregnancy and post-partumLéa Ghenassia-Fouillet, Antoine Morel, Paul Frappé, et al.
Jac-Antimicrobial Resistance|October 21, 2022
Overly broad-spectrum antibiotic treatment of wild-type <i>Pseudomonas aeruginosa</i> infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort studyClément Ourghanlian, Vincent Fihman, Antoine Morel, et al.
Journal of Contaminant Hydrology|January 29, 2026
Evaluation of the protection of aquifers against pollution risks in karstic areas (PAPRIKA) method for predicting Cryptosporidium contaminationDamien Costa, Maria A Stoica, Gladys Foissey, et al.
Clinical and Experimental Rheumatology|March 18, 2021
Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitisManon Martins, Antoine Morel, Charlotte Laurent, et al.
European Journal of Ophthalmology|September 16, 2022
CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belataceptAntoine Morel, Amina Chahrazed Debieb, David Mrejen, et al.
Journal of Nephrology|June 28, 2021
Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three yearsTristan de Nattes, Arnaud François, Sophie Candon, et al.
Scientific Reports|July 27, 2025
Podocyte dysfunction driven by heme in sickle-cell nephropathyChloé Ben Ali, Antoine Morel, Marion Morvan, et al.
Kidney International Reports|August 7, 2023
Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With BelataceptChloë Schwarz, Antoine Morel, Marie Matignon, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Clinical Kidney Journal|August 2, 2023
CD44 staining in parietal epithelial cells and early steroid response in patients with minimal change diseaseAntoine Morel, Philippe Remy, Hamza Sakhi, et al.
Pathology|November 14, 2021
Thrombospondin type-1 domain-containing 7A-related membranous nephropathy associated with glomerular AL amyloidosisAntoine Morel, David Buob, Jean-Michel Goujon, et al.
Phlebology|January 7, 2021
Management of superficial venous thrombosis in unevaluated situations: Cancer, severe renal impairment, pregnancy and post-partumLéa Ghenassia-Fouillet, Antoine Morel, Paul Frappé, et al.
Jac-Antimicrobial Resistance|October 21, 2022
Overly broad-spectrum antibiotic treatment of wild-type <i>Pseudomonas aeruginosa</i> infections in relation to the EUCAST new definition of susceptibility testing categories, a retrospective multicentre cohort studyClément Ourghanlian, Vincent Fihman, Antoine Morel, et al.
Journal of Contaminant Hydrology|January 29, 2026
Evaluation of the protection of aquifers against pollution risks in karstic areas (PAPRIKA) method for predicting Cryptosporidium contaminationDamien Costa, Maria A Stoica, Gladys Foissey, et al.
Clinical and Experimental Rheumatology|March 18, 2021
Belatacept as maintenance therapy in kidney transplant recipients with ANCA-associated vasculitisManon Martins, Antoine Morel, Charlotte Laurent, et al.
European Journal of Ophthalmology|September 16, 2022
CMV-related anterior and intermediate uveitis in a kidney transplant recipient treated with belataceptAntoine Morel, Amina Chahrazed Debieb, David Mrejen, et al.
Journal of Nephrology|June 28, 2021
Switch from calcineurin inhibitors to belatacept in kidney transplant patients with chronic-active antibody mediated rejection results in lower decline in kidney function at three yearsTristan de Nattes, Arnaud François, Sophie Candon, et al.
Scientific Reports|July 27, 2025
Podocyte dysfunction driven by heme in sickle-cell nephropathyChloé Ben Ali, Antoine Morel, Marion Morvan, et al.
Kidney International Reports|August 7, 2023
Hepatitis B Virus Reactivation in Kidney Transplant Recipients Treated With BelataceptChloë Schwarz, Antoine Morel, Marie Matignon, et al.
Pageof 4